$AZN news
The latest AZN stock news: headlines, filings, AI summaries and sentiment for $AZN, updated around the clock.
- AstraZeneca Acquires Preclinical Biotech Omniose to Enhance Vaccine Platform
- Olema Pharmaceuticals Reports Third Quarter GAAP EPS Miss
- Compugen Reports Q3 2026 Financial Results and Clinical Pipeline Updates
- Guardant Health Reports Strong Q3 2026 Growth Driven by Oncology and Screening Segments
- Rhythm Pharmaceuticals Shares Surge Following Report of AstraZeneca Acquisition Bid
- Royalty Pharma Reports Strong Q3 2026 Results and Raises Full-Year Guidance
- Amgen's Imdelltra Shows Significant Efficacy in Advanced Lung Cancer Treatment
- Weekly Healthcare Market Update: Focus on Eli Lilly, Merck, and AstraZeneca Amid Broad Market Decline
- AstraZeneca Reports Revenue Growth Driven by Oncology Expansion and Restructuring Initiatives
- AstraZeneca Reports Q3 2026 Results with Strong Oncology and Rare Disease Growth
- AstraZeneca Q3 Earnings Exceed Estimates Driven by Oncology Growth
- AstraZeneca Reports Q3 Earnings Beat and Reaffirms FY2026 Guidance
- Market Outlook: Energy Giants and Tech Earnings Drive Friday Trading Sentiment
- Major Energy and Pharmaceutical Earnings Scheduled for Friday Pre-Market
- AstraZeneca Scheduled to Report Q3 Earnings on October 30
- AstraZeneca Explores Development of mRNA Cancer Vaccines
- Amgen's Imdelltra Combination Therapy Reduces Death Risk by 58% in Extensive-Stage Small Cell Lung Cancer
- ESMO Congress Highlights Oncology Breakthroughs Amid Market Volatility and Fed Uncertainty
- AstraZeneca CEO Says Company Can Grow Without Major Acquisitions
- AstraZeneca CEO Discusses Summit Therapeutics' Drug as a Potential Game-Changer for Cancer Treatment
- AstraZeneca and Daiichi Sankyo Collaborate with Summit Therapeutics to Evaluate Combination Therapy
- Summit Therapeutics and AstraZeneca Announce $2 Billion Equity Investment Agreement
- NIH Funding Cuts Delay Promising Pediatric Brain Cancer Trials
- AstraZeneca Expands EU Approval of Asthma Inhaler Trixeo Aerosphere
- Novo Nordisk Stock Falls After Outlining Long-Term Growth Targets
- IonQ Announces Quantum Computing Breakthrough with Real-Time Error Decoder
- AstraZeneca and Daiichi Sankyo's Breast Cancer Drug Approved for NHS Use in England
- Vanguard Renewables Acquires North American Digesters from Generate Upcycle
- Ionis Pharmaceuticals Stock Falls Over 40% This Year Despite Analysts' Bullish Outlook
- China Unveils Ambitious Biomedical Industry Plan for Global Leadership by 2030
- AstraZeneca's Tozorakimab Shows Strong Results in COPD Trials
- Amgen Stock Drops Sharply Amid Novartis' Lp(a)-Lowering Drug Failure
- Innate Pharma Reports Q2 2026 Financial Results and Strategic Updates
- Tempus AI Shares Surge After Morgan Stanley Raises Revenue Outlook
- AstraZeneca-Daiichi Breast Cancer Drug Gets Approval in England
- Olema Pharmaceuticals Shares Drop After AstraZeneca Trial Fails to Meet Primary Endpoint
- AstraZeneca's Breast Cancer Drug Fails Late-Stage Trial, Citi Maintains 'Buy' Rating
- Investors Scrutinize Novartis' M&A Strategy After Drug Trial Setbacks
- Karyopharm delays debt payment; Amgen explores expanded use for Imdelltra
- Positive Lung Cancer Trial Results for Amgen's Imdelltra and AstraZeneca's Imfinzi
- Deutsche Bank Maintains 'Sell' Rating on AstraZeneca Despite Positive Drug Data
- China’s Biopharma Rise Faces Challenges Despite Growth
- Amgen Shares Drop After Novartis Fails Cholesterol Drug Trial
- AstraZeneca's COPD Drug Shows Strong Trial Results and Blockbuster Potential
- Harbour BioMed Included in Stock Connect, Reflecting Market Recognition
- AstraZeneca receives FDA accelerated approval for camizestrant in combination therapy for specific breast cancer
- Ionis Pharmaceuticals' Sell-Off Was Overdone Despite Clinical Setbacks
- Ionis Pharmaceuticals' Sell-Off Was Overdone Despite Clinical Setbacks
- Owkin partners with Boehringer Ingelheim for AI-driven drug discovery
- AstraZeneca and Hutchmed Report Positive Results from Lung Cancer Trial